Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA has approved a new anti-tumor necrosis factor alpha (TNF alpha) drug for the treatment of rheumatoid arthritis (RA).

Pharmacology Update: Adalimumab — Humira